Abbott faces US criminal investigation over baby formula: Report

Published On 2023-01-22 10:00 GMT   |   Update On 2023-01-22 10:00 GMT
Advertisement

US: Abbott Laboratories' Michigan plant, which was at the center of the U.S. baby formula shortage last year, faces a criminal investigation by the Justice Department, the Wall Street Journal reported on Friday.

Panicked parents emptied baby formula aisles at supermarkets last year as a recall of formulas by Abbott due to complaints of bacterial infections exacerbated a shortage that began due to pandemic-induced supply chain issues.

Advertisement

The White House intervened to address the shortage.

Attorneys with the Justice Department's consumer-protection branch are conducting the criminal investigation, the WSJ report said, citing people familiar with the matter.

"DOJ has informed us of its investigation and we're cooperating fully," an Abbott spokesman told Reuters, without commenting further on the nature of the probe. The DOJ did not immediately respond to a request for comment.

In February 2022, Abbott, the biggest U.S. supplier of baby formula, recalled Similac and other infant formula products produced at the Michigan facility after reports of bacterial infections in babies who had consumed products made there.

The U.S. Food and Drug Administration found "shocking" results during an inspection such as cracks in vital equipment, a lack of adequate hand-washing, and evidence of previous bacterial contamination. The regulator and the company later reached an agreement that allowed the plant to reopen.

Read also: Abbott recalls some ready-to-feed baby formula liquid products including Similac

Tags:    
Article Source : Reuters

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Similar News